Filtered By:
Source: Circulation: Cardiovascular Quality and Outcomes
Condition: Stroke
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 429 results found since Jan 2013.
Abstract 127: Cardiovascular Risk and Outcomes in Patients with Diabetes: Using Medical Education to Improve Care Session Title: Poster Session I
Conclusion: This study demonstrated the success of a curriculum-style educational intervention using multimedia technology on improving knowledge and performance of cardiologists which can lead to enhanced management of CV risks and, thus, improved outcomes in patients with T2D and CVD.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Larkin, A., Healy, C. Tags: Session Title: Poster Session I Source Type: research
Abstract 136: Impact of Abnormal Ventricular Conduction on TAVR Outcomes Session Title: Poster Session I
Conclusion: Despite association with decreased ejection fraction and lower aortic valve gradient, electrocardiographic conduction delays do not lead to inferior TAVR outcomes.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Marthy, A., Delago, A., Elkharbotly, A., Bulibek, B., El-Hajjar, M., Torosoff, M. Tags: Session Title: Poster Session I Source Type: research
Abstract 140: Women of Color: Where Race/Ethnicity, Sex/Gender, Culture and History Affect Cardiovascular Health and Disparities Session Title: Poster Session I
The United States is in the midst of a historic demographic shift in its population that will have multiple societal impacts including healthcare issues. In 2043 it is predicted that the majority of the US population will be persons of color ("racial and ethnic minorities"). This new majority will be 53.4% of the nation by 2050. Of the 49 million uninsured in the US in 2011, 55% were persons of color who were only 33% of the population. Women of color are projected to increase in number from 57 million in 2010 to 107 million in 2050, from 36 percent to 53 percent of the total US female population. The Women of Color Health...
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Brooks, C. E., Mistretta, A., Brewinski-Isaacs, M., Miller, L., Cornelison, T. L., Clayton, J. A. Tags: Session Title: Poster Session I Source Type: research
Abstract 142: Primary Endpoint Results from a Community-Based Registry Evaluating the Use of a Blood-Based Age/Sex/Gene Expression Test in Patients Presenting with Symptoms Suggestive of Obstructive Coronary Artery Disease: the PRESET Registry (A Registry to Evaluate Patterns of Care Associated with the Use of Corus(R) CAD in Real World Clinical Care Settings) Session Title: Poster Session I
Conclusion: In this analysis of a community-based cardiovascular registry, the age/ex/gene expression test was adopted in clinical practice and associated with a statistically significant and clinically relevant effect on medical decision making in patients presenting with typical or atypical symptoms suggestive of obstructive CAD. The use of the ASGES test showed clinical utility in helping clinicians efficiently and safely rule out obstructive CAD as the cause of their patients’ symptoms, thereby minimizing potentially unnecessary referral of low risk patients to cardiology and further cardiac diagnostic testing.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Ladapo, J. A., Budoff, M., Ross, L., Huang, L., Sharp, D., Maniet, B., Monane, M., Pokrywka, G. S., Wright, R. F. Tags: Session Title: Poster Session I Source Type: research
Abstract 144: Cost of Cardiovascular Disease Episodes among Patients with Hypertension Session Title: Poster Session I
Conclusions: Cost estimates of CVD episodes among hypertensive patients are consistent with results from the scarce literature in this area. Moreover, our study finds evidence of increased medical resource utilization weeks before the recording of the CVD episode. Omitting these pre-event costs leads to an underestimate of the true costs of CVD.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Arrieta, A., Qiao, N., Woods, J. R., Jay, S. J., Veledar, E., Nasir, K. Tags: Session Title: Poster Session I Source Type: research
Abstract 146: Clinical and Economic Consequences of Statin Intolerance in the U.S.: Results from an Integrated Health System Session Title: Poster Session I
Conclusion: While the majority of SI patients were on a statin, SI patients demonstrate a higher risk of some cardiovascular events; incur higher healthcare costs; and difficulty reaching LDL-C goals compared to patients without SI. Alternative treatment strategies are needed to better serve this at-risk patient population.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Sanchez, R. J., Graham, J. H., Evans, M. A., Mallya, U. G., Panaccio, M. P., Steinhubl, S. R. Tags: Session Title: Poster Session I Source Type: research
Abstract 150: Antithrombotic Use in Nonvalvular Atrial Fibrillation (NVAF): Alignment between Guidelines and Emerging Evidence with Clinician Prescribing Preferences Session Title: Poster Session I
Conclusions: Similar to findings from indirect treatment comparison studies, physicians largely prefer NOACs_particularly apixaban_compared to warfarin or aspirin for stroke risk reduction in NVAF patients. Additional research is needed to determine why NOACs are underused in practice.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Shafrin, J., Bruno, A., MacEwan, J. P., Campinha-Bacote, A., Trocio, J., Tan, W., Romley, J. A. Tags: Session Title: Poster Session I Source Type: research
Abstract 152: Persistence of Warfarin versus Dabigatran Therapy in Patients with Atrial Fibrillation: Results from the ORBIT AF Registry Session Title: Poster Session I
Conclusion: Persistence rates for warfarin were higher at one year than those on dabigatran. In addition, factors associated with persistence of warfarin include: African American and Hispanic race, type of AF including permanent and persistent, LVH, and CHA2DS2-VASc risk scores ≥ 2.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Jackson, L. R., Kim, S., Shrader, P., Blanco, R., Thomas, L., Ansell, J., Fonarow, G. C., Gersh, B. J., Go, A. S., Kowey, P., Mahaffey, K. W., Hylek, E. M., Burton, P., Peterson, E. D., Piccini, J. P. Tags: Session Title: Poster Session I Source Type: research
Abstract 157: An Early Assessment of Hospital Readmissions Among Nonvalvular Atrial Fibrillation Treated with the New Oral Anticoagulants, Apixaban, Dabigatran, and Rivaroxaban Session Title: Poster Session I
Conclusion: In this early assessment, treatment with rivaroxaban vs. apixaban was associated with greater risk of all-cause or bleeding-related 1-month readmissions and higher hospital costs due to readmissions.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Deitelzweig, S., Bruno, A., Trocio, J., Tate, N., Lin, J., Lingohr-Smith, M. Tags: Session Title: Poster Session I Source Type: research
Abstract 164: A Field Synopsis of Gender Effects in Clinical Prediction Models for Cardiovascular Disease Session Title: Poster Session I
Conclusions: Gender is an important prognostic factor in CVD, but is only included in about one third of published CPMs. Gender is much more frequently included as a predictor of incident CVD among the disease-free than of prognosis in those with established CVD.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Paulus, J. K., Lai, L., Raman, G., Lutz, J. S., Wessler, B. S., Kent, D. M. Tags: Session Title: Poster Session I Source Type: research
Abstract 166: Developing the Veterans Affairs Cardiac Risk Score Session Title: Poster Session I
Conclusion: We demonstrated that an EHR in a specific population could risk-stratify patients as well those from as organized cohort studies and greatly improve calibration. Further, our finding that the ASCVD score greatly underpredicted in our population, while previous work have reported the ASCVD over-predictind in other cohorts, suggests that rather than arguing about which risk tool is best, our patients may be better served by us focusing on calibrating CV risk tools for our specific patient population using their EHR data.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Sussman, J. B., Wiitala, W., Hofer, T., Zawitowski, M., Vijan, S., Hayward, R. Tags: Session Title: Poster Session I Source Type: research
Abstract 174: Clinical Prediction Models for Cardiovascular Disease: The Tufts PACE CPM Database Session Title: Poster Session I
Conclusions: There is an abundance of CPMs available for many CVD conditions, with substantial redundancy in the literature. The comparative performance of these models, the consistency of effects and risk estimates across models and the actual and potential clinical impact of this body of literature is poorly understood.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Wessler, B. S., Lai YH, L., Kramer, W., Cangelosi, M., Raman, G., Lutz, J., Kent, D. M. Tags: Session Title: Poster Session I Source Type: research
Abstract 176: Variation in the Content and Timing of Informed Consent in Cardiovascular Procedures: An Opportunity to Improve Decision-making Session Title: Poster Session I
Conclusion: We observed notable variation in the content, legibility and timing of informed consent documents within and across procedures. These components are necessary, though may not be sufficient, to support a high-quality informed consent process. Our results highlight opportunities for improving informed consent. Standardization of content and increased time for patients to consider the risks, benefits, and alternatives of elective procedures may result in higher quality decision-making and facilitate patient autonomy.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Shahu, A., Spatz, E. S., Schwartz, J., Searfoss, R., Perez, M., Eddy, E., Schroeder, L. M., Bernheim, S. M., Krumholz, H. M. Tags: Session Title: Poster Session I Source Type: research
Abstract 201: Increased Frequency of Early Dispensed but Unused Tpa Shortens Door to Needle Times in Potentially Eligible Thrombolysis Patients Presenting to a Tertiary Stroke Center Session Title: Poster Session II
Conclusion: Implementing a strategy of early dispensing of tPA for potentially eligible stroke patients was correlated with significant reductions in DTN times, with median DTN times per quarter consistently below 45 min in the final year. Our data remained significant even after adjusting for stroke severity. These data support the use of the early dispensing strategy recommended by Target Stroke to further reduce DTN times. Further research is warranted to confirm these findings.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Siddiqui, K. A., Ali, S. F., Anderson, C. D., Rost, N., Schwamm, L. H. Tags: Session Title: Poster Session II Source Type: research
Abstract 202: The NIH Stroke Scale Can Miss Improvement After IV tPA For Acute Ischemic Stroke Session Title: Poster Session II
Conclusion: The NIHSS may inadequately capture functional improvement post-treatment, especially in the days immediately following intervention.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Marsh, E. B., Lawrence, E., Llinas, R. H. Tags: Session Title: Poster Session II Source Type: research
